Viking Therapeutics has formed a mutually beneficial alliance with U.S. biopharmaceutical companies to develop and manufacture its Eli Lilly and the Vikings' partnership with USA Tirzepatide Firm Corporation for enhanced supply chain for Liraglutide, Victoza, Saxenda, Exenatide, Byetta, Semaglutide, Ozempic, Rybelsus, Wegovy, Lixisenatide, Adlyxin,